Pathways Knowlegdes
Necessitatibus eius consequatur ex aliquid fuga eum quidem sint consectetur velit
| Pathway | DOIs | Note |
|---|---|---|
| lysine biosynthesis IV Accession ID: BioCyc:PCHR_LYSINE-AMINOAD-PWY |
- | |
| lysine degradation II Accession ID: BioCyc:MOUSE_LYSINE-DEG1-PWY |
- | |
| Biochemical pathways: part I Accession ID: WikiPathways:WP3604 |
|
Michal G. On representation of metabolic pathways. Biosystems. 1998 Jun;47(1-2):1–7. doi: 10.1016/s0303-2647(98)00019-7. PMID: 9715748. |
| Metabolic Epileptic Disorders Accession ID: WikiPathways:WP5355 |
|
Tan M, Mosaoa R, Graham GT, Kasprzyk-Pawelec A, Gadre S, Parasido E, Catalina-Rodriguez O, Foley P, Giaccone G, Cheema A, Kallakury B, Albanese C, Yi C, Avantaggiati ML. Inhibition of the mitochondrial citrate carrier, Slc25a1, reverts steatosis, glucose intolerance, and inflammation in preclinical models of NAFLD/NASH. Cell Death & Differentiation. 2020 Jan 20;27(7):2143–57. doi: 10.1038/s41418-020-0491-6. |
| Lysine Metabolism Accession ID: PathBank:SMP0002434 |
- |